Interferon beta-induced panniculitis mimicking acute appendicitis

Archives of Dermatology

Volumn 145, Issue 8, 2009, Pages 916-917

  Poulin, Frédéric ^a   Rico, Philippe ^a   Côté, Jean ^a   Bégin, Louis R ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA1 INTERFERON; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ACUTE APPENDICITIS; ADULT; APPENDECTOMY; ARTICLE; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG SUBSTITUTION; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN TISSUE; INJECTION SITE DERMATITIS; INJECTION SITE INFECTION; LAPAROSCOPIC SURGERY; LEUKOCYTOSIS; LIQUEFACTION; LYMPHOCYTIC INFILTRATION; MULTIPLE SCLEROSIS; PANNICULITIS; PRIORITY JOURNAL; RECTUS ABDOMINIS MUSCLE; SKIN BIOPSY; SKIN INDURATION; SUBCUTANEOUS FAT;

ABDOMINAL WALL; ADJUVANTS, IMMUNOLOGIC; ADULT; APPENDICITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON-BETA; MULTIPLE SCLEROSIS; PANNICULITIS; RECOMBINANT PROTEINS;

EID: 68949143004     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.106     Document Type: Article

References (5)

1. Walther EU, Hohlfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology. 1999;53(8):1622-1627.
2. Heinzerling L, Dummer R, Burg G, Schmid-Grendelmeier P. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol. 2002;12(2):194-197.
3. O'Sullivan SS, Cronin EM, Sweeney BJ, Bourke JF, Fitzgibbon J. Panniculitis and lipoatrophy after subcutaneous injection of interferon beta-1b in a patient with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2006;77(12):1382-1383.
4. Elgart GW, Sheremata W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol. 1997;37(4):553-558.
5. Buttmann M, Goebeler M, Toksoy A, et al. Subcutaneous interferon-beta injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction. J Neuroimmunol. 2005;168(1-2):175-182.